10321-49-0

Basic information

• Product Name: 4-BROMO-ISOQUINOLIN-3-YLAMINE
• Synonyms: 4-BROMO-ISOQUINOLIN-3-YLAMINE;4-BroMoisoquinolin-3-aMine;3-IsoquinolinaMine, 4-broMo-;3-Amino-4-bromoisoquinoline;4-Bromoisoquinoline-3-amine
• CAS NO: 10321-49-0
• Molecular Formula: C₉H₇BrN₂
• Molecular Weight: 223.07
• Mol File: 10321-49-0.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-BROMO-ISOQUINOLIN-3-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-ISOQUINOLIN-3-YLAMINE(10321-49-0)
• EPA Substance Registry System: 4-BROMO-ISOQUINOLIN-3-YLAMINE(10321-49-0)

Safety Data

• Hazardous Substances Data: 10321-49-0(Hazardous Substances Data)

Usage

General Description

4-Bromo-isoquinolin-3-ylamine is a chemical compound that contains a bromine atom and an amine group attached to an isoquinoline ring. It is used in the synthesis of pharmaceuticals and other organic compounds. It can be utilized as a building block for the preparation of a variety of biologically active compounds, including potential drugs and chemical probes for research applications. The presence of the bromine atom and the amine group makes this compound a versatile starting material for the preparation of diverse molecular scaffolds and functional groups, making it a valuable tool for organic chemists and drug developers. Additionally, it can be used in the development of new synthetic methodologies and chemical processes.

Upstream product

• 25475-67-6 isoquinolin-3-amine 

Downstream Products

• 1100243-02-4 4-bromo-N-phenylisoquinolin-3-amine 
• 1100243-05-7 4-bromo-N-(2-bromophenyl)isoquinolin-3-amine 
• 25475-67-6 isoquinolin-3-amine 

Relevant articles and documents

-

-

HETEROCYCLIC COMPOUNDS AND USES THEREOF

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase a

SULFONAMIDE COMPOUND

The present invention provides novel sulfonamide compounds having TRPM8 antagonistic activity which are useful as medicaments. Specifically, the present invention provides a sulfonamide compound of the formula (I): wherein Ring A is the following formula (i), (ii), or (ix): R4 is optionally substituted alkyl, X1 and X2 are each independently tetrazolyl, tetrazolinonyl, optionally substituted triazolyl, triazolinonyl, oxadiazolonyl, optionally substituted alkanoylaminomethyl, or optionally substituted alkylsulfonylaminomethyl, or R4 and X2 combine with each other at their terminals together with the adjacent benzene to form indazolinonyl or benzoisoxazolonyl, and the other symbols are the same as described in the specification, or a pharmaceutically acceptable salt thereof.